122 related articles for article (PubMed ID: 9283586)
1. DNA hypomethylation in breast cancer: an independent parameter of tumor progression?
Bernardino J; Roux C; Almeida A; Vogt N; Gibaud A; Gerbault-Seureau M; Magdelenat H; Bourgeois CA; Malfoy B; Dutrillaux B
Cancer Genet Cytogenet; 1997 Sep; 97(2):83-9. PubMed ID: 9283586
[TBL] [Abstract][Full Text] [Related]
2. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression.
Soares J; Pinto AE; Cunha CV; André S; Barão I; Sousa JM; Cravo M
Cancer; 1999 Jan; 85(1):112-8. PubMed ID: 9921982
[TBL] [Abstract][Full Text] [Related]
3. Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y
Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of DNA ploidy and S-phase estimate in primary breast cancer: a prospective study.
Dieterich B; Albe X; Vassilakos P; Wieser S; Friedrich R; Krauer F
Int J Cancer; 1995 Sep; 63(1):49-54. PubMed ID: 7558451
[TBL] [Abstract][Full Text] [Related]
5. Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
Graff-Baker AN; Orozco JIJ; Marzese DM; Salomon MP; Hoon DSB; Goldfarb M
Ann Surg Oncol; 2018 Oct; 25(10):3082-3087. PubMed ID: 29956094
[TBL] [Abstract][Full Text] [Related]
6. DNA hypomethylation is prevalent even in low-grade breast cancers.
Jackson K; Yu MC; Arakawa K; Fiala E; Youn B; Fiegl H; Müller-Holzner E; Widschwendter M; Ehrlich M
Cancer Biol Ther; 2004 Dec; 3(12):1225-31. PubMed ID: 15539937
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor gene methylation in human breast tumors.
Falette NS; Fuqua SA; Chamness GC; Cheah MS; Greene GL; McGuire WL
Cancer Res; 1990 Jul; 50(13):3974-8. PubMed ID: 2354445
[TBL] [Abstract][Full Text] [Related]
9. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer in young women (< or = 35 years): Genomic aberrations detected by comparative genomic hybridization.
Weber-Mangal S; Sinn HP; Popp S; Klaes R; Emig R; Bentz M; Mansmann U; Bastert G; Bartram CR; Jauch A
Int J Cancer; 2003 Nov; 107(4):583-92. PubMed ID: 14520696
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory and Non-inflammatory Breast Cancer: A Potential Role for Detection of Multiple Viral DNAs in Disease Progression.
El-Shinawi M; Mohamed HT; Abdel-Fattah HH; Ibrahim SA; El-Halawany MS; Nouh MA; Schneider RJ; Mohamed MM
Ann Surg Oncol; 2016 Feb; 23(2):494-502. PubMed ID: 26508152
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
Nass SJ; Herman JG; Gabrielson E; Iversen PW; Parl FF; Davidson NE; Graff JR
Cancer Res; 2000 Aug; 60(16):4346-8. PubMed ID: 10969774
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal alterations associated with the transition from in situ to invasive breast cancer.
Ellsworth RE; Vertrees A; Love B; Hooke JA; Ellsworth DL; Shriver CD
Ann Surg Oncol; 2008 Sep; 15(9):2519-25. PubMed ID: 18622645
[TBL] [Abstract][Full Text] [Related]
15. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
[TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Wang BL; Chen L; Yang WT; Shen ZZ; Huang W; Shao ZM
Hum Pathol; 2010 Jan; 41(1):48-58. PubMed ID: 19733895
[TBL] [Abstract][Full Text] [Related]
17. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
18. Examination of DNA methylation of chromosomal hot spots associated with breast cancer.
Kass DH; Shen M; Appel NB; Anderson DE; Saunders GF
Anticancer Res; 1993; 13(5A):1245-51. PubMed ID: 8239493
[TBL] [Abstract][Full Text] [Related]
19. Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer.
Pinto AE; Mendonça E; André S; Nóbrega SD; Soares J
Anal Quant Cytol Histol; 2002 Dec; 24(6):345-54. PubMed ID: 12508694
[TBL] [Abstract][Full Text] [Related]
20. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
Kapranos N; Kounelis S; Karantasis H; Kouri E
Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
